The Staff Investigators at UPCI are excellent physician scientists providing distinctive leadership in the scientific endeavors of UPCI that extends beyond their individual research activities. They are innportant contributors to the interprogramnnatic activities and fulfill the translational objectives ofthe scientific programs. Dr. David Bartlett is a Clinical Staff Investigator providing a significant contribution to the clinical research activities of UPCI. He provides oversight for the multidisciplinary specialty care clinics, tumor boards and provides integration of the clinicla research activities as they relate to each disease site. Dr. Soldano Ferrone is a Research Staff Investigator with extensive experience in cancer biology and immunotherapy. He serves a unique role as a resource for the scientific community at UPCI to design immunixation protocols, screening procedures and characterization strategies of antibodies to clinically relevant molecules. This library of monoclonal antibodies represents a useful source of reagents for the entire UPCI reseach community. Dr. Ferrone is also involved in the research and career development of junior faculty and is responsible for the mentorship program for junior faculty. Dr. IVIichael Lotze has a unique role in UPCI and develops relationships with outside academic institutions, biotechnology and pharaceutical firms of strategic importance forthe UPCI. He is the UPCI representative to the Cancer Biology Training Consortium (CABTRAC) and is a mentor to several UPCI junior faculty. We are requesting support for 1.2 calendar months for each of these three UPCI Staff Investigators who have major programmatic responsibilities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA047904-25
Application #
8519318
Study Section
Special Emphasis Panel (ZCA1-RTRB-L)
Project Start
Project End
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
25
Fiscal Year
2013
Total Cost
$102,795
Indirect Cost
$69,737
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Chen, Dongshi; Ni, Hong-Min; Wang, Lei et al. (2018) PUMA induction mediates acetaminophen-induced necrosis and liver injury. Hepatology :
Tahata, Shawn; Singh, Shivendra V; Lin, Yan et al. (2018) Evaluation of Biodistribution of Sulforaphane after Administration of Oral Broccoli Sprout Extract in Melanoma Patients with Multiple Atypical Nevi. Cancer Prev Res (Phila) 11:429-438
Moravcikova, Erika; Meyer, E Michael; Corselli, Mirko et al. (2018) Proteomic Profiling of Native Unpassaged and Culture-Expanded Mesenchymal Stromal Cells (MSC). Cytometry A 93:894-904
Samuelsson, Laura B; Bovbjerg, Dana H; Roecklein, Kathryn A et al. (2018) Sleep and circadian disruption and incident breast cancer risk: An evidence-based and theoretical review. Neurosci Biobehav Rev 84:35-48
Shiffman, Saul; Mao, Jason M; Kurland, Brenda F et al. (2018) Do non-daily smokers compensate for reduced cigarette consumption when smoking very-low-nicotine-content cigarettes? Psychopharmacology (Berl) 235:3435-3441
Cao, Chunyu; Wu, Hao; Vasilatos, Shauna N et al. (2018) HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells. Int J Cancer 143:1388-1401
Yochum, Zachary A; Cades, Jessica; Wang, Hailun et al. (2018) Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer. Oncogene :
Beumer, Jan H; Inker, Lesley A; Levey, Andrew S (2018) Improving Carboplatin Dosing Based on EstimatedĀ GFR. Am J Kidney Dis 71:163-165
Tong, Jingshan; Zheng, Xingnan; Tan, Xiao et al. (2018) Mcl-1 Phosphorylation without Degradation Mediates Sensitivity to HDAC Inhibitors by Liberating BH3-Only Proteins. Cancer Res 78:4704-4715
Menk, Ashley V; Scharping, Nicole E; Rivadeneira, Dayana B et al. (2018) 4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses. J Exp Med 215:1091-1100

Showing the most recent 10 out of 1187 publications